Private Market View

Kano Therapeutics

Biotechnology · Cambridge, MA · Founded 2021 · Privately Held (backing)

Last price · $/share
Implied valuation
$15.0M
Total raised
$7.4M
Last round
Seed Round
Aug 2024
What is Kano Therapeutics worth?
$15.0Mlast known valuation

Kano Therapeutics last raised $5.0M in its Seed Round (Aug 2024).

Free account
See the evidence behind this price
  • ·Post-money valuations for all 2 rounds
  • ·The complete investor list — 12 names
  • ·Watchlist + deal alerts for Kano Therapeutics
Create free account
No card required

Funding history

2 rounds
DateRoundRaisedPost-money
Aug 2024Seed Round$5.0M
May 2022Seed Round$2.1M

How Kano Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Kano Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

What is Kano Therapeutics worth?
Kano Therapeutics's last known valuation is $15.0M.
How much has Kano Therapeutics raised?
Kano Therapeutics has raised $7.4M in total funding across 2 recorded rounds.
When did Kano Therapeutics last raise?
Kano Therapeutics last raised in Aug 2024 (Seed Round), raising $5.0M.